Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Century Therapeutics Inc shares valued at $1,267 were sold by Farid Adrienne on Nov 04 ’24. At $1.23 per share, Farid Adrienne sold 1,033 shares. The insider’s holdings dropped to 135,130 shares worth approximately $0.18 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Carr Douglas sold 283 shares, netting a total of over 347 in proceeds. Following the sale of shares at $1.23 each, the insider now holds 317,147 shares.
Before that, Farid Adrienne had added 1,033 shares to its account. In a trade valued at $1,268, the Officer bought Century Therapeutics Inc shares for $1.23 each.
As published in their initiating research note from Rodman & Renshaw on August 08, 2024, Century Therapeutics Inc [IPSC] has been a Buy and the price target has been revised to $6. Analysts at JP Morgan downgraded the stock from ‘”an Overweight”‘ to ‘”a Neutral”‘ outlook in a report released in late August. As of December 27, 2022, Chardan Capital Markets has initiated its “Buy” rating for IPSC. Earlier on October 31, 2022, Guggenheim initiated its rating. Their recommendation was “a Buy” for IPSC stock.
Analyzing IPSC Stock Performance
During the last five days, there has been a drop of approximately -4.32%. Over the course of the year, Century Therapeutics Inc shares have dropped approximately -59.94%. Shares of the company reached a 52-week high of $5.5100 on 03/08/24 and a 52-week low of $1.1400 on 10/31/24. A 50-day SMA is recorded $1.4959, while a 200-day SMA reached $2.7591. Nevertheless, trading volume fell to 0.68 million shares from 0.4 million shares the previous day.
Support And Resistance Levels for Century Therapeutics Inc (IPSC)
According to the 24-hour chart, there is a support level at 1.2667, which, if violated, would cause prices to drop to 1.2033. In the upper region, resistance lies at 1.4467. The next price resistance is at 1.5633. RSI (Relative Strength Index) is 43.16 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.0512, which suggests the price will decrease in the coming days. Percent R is at 55.75%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
